Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

DermTech, Inc. (DMTKQ) had Revenue of $15.30M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$15.30M
Net Income	$-100.89M
Cost of Goods Sold	$15.02M
Gross Profit	$0.28M
Operating Expenses	$119.03M
Operating Income	$-103.74M
Non-Operating Income/Expense	$2.85M
Pre-Tax Income	$-100.89M
Normalized Pre-Tax Income	$-100.89M
Income after Taxes	$-100.89M
Income from Continuous Operations	$-100.89M
Consolidated Net Income/Loss	$-100.89M
Normalized Income after Taxes	$-100.89M
EBIT	$-103.74M
EBITDA	$-98.42M
Weighted-Average Shares Outstanding (Basic)	32.64M
Weighted-Average Shares Outstanding (Diluted)	32.64M
Earnings per Share (EPS) (Basic)	$-3.09
Earnings per Share (EPS) (Diluted)	$-3.09
Balance Sheet Financials
Current Assets	$61.75M
Property, Plant, and Equipment	$4.99M
Long-Term Assets	$60.18M
Total Assets	$121.93M
Current Liabilities	$13.45M
Long-Term Debt	$0.04M
Long-Term Liabilities	$51.31M
Total Liabilities	$64.75M
Common Equity	$57.17M
Tangible Shareholders Equity	$57.17M
Shareholders Equity	$57.17M
Common Shares Outstanding	34.52M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-76.98M
Cash Flow from Investing Activities	$29.86M
Cash Flow from Financial Activities	$6.08M
Beginning Cash	$81.25M
End Cash	$40.21M
Increase/Decrease in Cash	$-41.04M
Stock-Based Compensation	$18.57M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.59
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.00
Debt to Equity Ratio	0.00
Gross Margin	1.80%
Operating Margin	-678.21%
EBIT Margin	-678.21%
EBITDA Margin	-643.43%
Pre-Tax Profit Margin	-659.57%
Profit Margin	-659.57%
Free Cash Flow	$-77.88M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	14.96
Receiveable Turnover	5.92
Days Sales in Receivables	61.66
Return on Equity	-176.45%
Return on Tangible Equity	-176.45%
Return on Assets	-82.74%
Return on Investments	-176.34%
Book Value Per Share	$1.66
Free Cash Flow per Share	$-2.39
Operating Cash Flow per Share	$-2.36

Data from Zacks Investment Research, Inc.